Status:
COMPLETED
Effect of Rate-responsive Compared to VDD Pacing in Cardiac Resynchronization Therapy Recipients
Lead Sponsor:
Ospedale Centrale Bolzano
Conditions:
Heart Failure, Wide QRS Complex
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to understand the best programming pacing mode for cardiac resynchronization therapy devices used to treat chronic heart failure.
Detailed Description
Cardiac resynchronization therapy (CRT) efficacy trials to date used atrial-synchronous biventricular pacing wherein there is no or minimal atrial pacing. However, bradycardia and chronotropic incompe...
Eligibility Criteria
Inclusion
- Patients willing to participate in the study and signing the approved Patient Informed Consent (PIC) Form;
- Patients with approved indication for CRT by European Society of Cardiology/European Heart Rhythm Association guidelines (ESC/EHRA).
- Sinus rhythm at the time of CRT device implantation with heart rate at rest above 50 bpm.
Exclusion
- Permanent Atrial Fibrillation;
- Inability to perform 6MWT;
- Suboptimal HF drug therapy;
- Heart rate at rest above 50 bpm.
Key Trial Info
Start Date :
November 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 17 2021
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT06592690
Start Date
November 27 2017
End Date
September 17 2021
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Centrale di Bolzano
Bolzano, Italy